Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00209040 · ClinicalTrials.gov registry record · NA
Fear Potentiation and Fear Inhibition in Posttraumatic Stress Disorder
A NA study, sponsored by Emory University.
- Completed
- Registry status
- NA
- Development phase
- 425
- Enrollment target
NCT00209040: Completed NA study, sponsored by Emory University.
NCT00209040 is a NA study that has completed, run by Emory University. The registered enrollment target is 425 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (70% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00209040, a NA study, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- NA
- Development phase
- 425 participants
- Enrollment target
Study Summary
The current study will investigate the ability of people with and without fear symptoms after trauma to inhibit fear in an experimental situation.
Primary Outcome
Percent change in acoustic startle magnitude during visual cue conditioned to aversive stimuli, compared to trials without aversive stimuli
Interventions
- BEHAVIORAL Acoustic Startle Testing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 425 participants |
| Start Date | 2001-01 |
| Est. Completion | 2012-02-22 |
| Phase | NA |
What the finished NCT00209040 record still lists
NCT00209040 is an interventional study that assigns participants to a tested intervention. The registered 425 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (70% lower).
The record links to 0 conditions, and to 1 intervention - of which Acoustic Startle Testing is the first listed.
NCT00209040 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00209040 about?
NCT00209040 is a clinical study titled "Fear Potentiation and Fear Inhibition in Posttraumatic Stress Disorder". The current study will investigate the ability of people with and without fear symptoms after trauma to inhibit fear in an experimental situation.
What is the current status of trial NCT00209040?
This trial is currently completed. It is a NA study. The enrollment target is 425 participants. The study started on 2001-01. Estimated completion is 2012-02-22.
What interventions are being tested in trial NCT00209040?
The interventions under investigation include: Acoustic Startle Testing (BEHAVIORAL).
Who is sponsoring clinical trial NCT00209040?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00209040's enrollment target sits among peer trials
425 236th of 2000 higher than 1,763 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04265430 · 425 participants · Phase 4
Serial Magnetic Resonance Imaging for the Prediction of Radiation-Induced Changes in Normal Tissue of Patients With Oral Cavity or Skull Base Tumors
- NCT04278690 · 425 participants · NA
Supporting Safe Use of Medications by Parents After Infant Discharge From the Neonatal Intensive Care Unit
- NCT05321368 · 425 participants · NA
A Cardiometabolic Health Program Linked With Clinical-Community Support and Mobile Health Telemonitoring to Reduce Health Disparities
- NCT05340738 · 425 participants · NA
AI-Based Fidelity Feedback to Enhance CBT
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia